Neuropace, Inc. NPCE Inventory write-downs
Inventory write-downs at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InventoryWriteDown.
The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s inventory write-downs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s inventory write-downs?
- Neuropace, Inc. (NPCE) reported inventory write-downs of $76K in Q1 2026.
- How has Neuropace, Inc.'s inventory write-downs changed year-over-year?
- Neuropace, Inc.'s inventory write-downs increased by 72.7% year-over-year, from $44K to $76K.
- What is the long-term trend for Neuropace, Inc.'s inventory write-downs?
- Over 4 years (2021 to 2025), Neuropace, Inc.'s inventory write-downs has grown at a -10.0% compound annual growth rate (CAGR), from $242K to $159K.
- What does inventory write-downs mean?
- This reflects the reduction in the carrying value of inventory when its market value falls below its cost due to obsolescence, damage, or declining demand. It serves as a key indicator of inventory management efficiency and the potential risk of product lifecycle issues. Frequent or large write-downs suggest challenges in demand forecasting or product quality control.